Participated · Equity · Aug 2026

Etched.ai develops rack-scale inference systems and broader frontier inference infrastructure. Since founding, the company has grown to more than 400 employees, hiring over 200 people after its Series B late last year. It has secured more than $1 billion in customer orders and established deep manufacturing and supply-chain partnerships, including opening a factory in Taiwan. Etched is currently validating its first rack-scale inference product with customers. The company’s near-term plans emphasize production, manufacturing scale-up, and deployment of its inference systems, supported by cumulative funding of $800 million.

Participated · Series F · Jun 2026

Ramp started as an expense-management platform and has expanded into payments, fraud detection, procurement, vendor management and accounting while integrating AI capabilities across its product suite. The company says it has more than 70,000 customers, including Visa, Uber, Shopify, Anduril and Figma, up from 50,000 last November. Ramp reported annualized revenue of more than $1 billion (with Bloomberg reporting a run-rate above $1.5 billion) and said it has reached positive free cash flow. It has launched AI-focused features such as AI agents for procurement, expense management, accounting and budgeting, and even a corporate credit card intended for AI-agent use. Ramp has raised over $3 billion in total capital to date. Management has indicated an eventual aim to go public, though no timing was given.

Led · Equity · May 2026

Founded in July 2024, Kela Technologies builds an open-architecture command-and-control platform designed to integrate sensors, radar, drones and weapons to create a unified real-time picture for border operations. The company has rapidly grown from dozens to about 150 employees and primarily serves Israel’s Ministry of Defense, deploying its systems to a high double-digit number of outposts across multiple borders. Kela reported roughly $20 million in revenue in 2025 and sources say it signed over $50 million in contracts last year, while moving from development into field deployment and production. The company opened a factory in southern Israel that includes ammunition production and has focused on integrating both its own and third-party UAVs and mini-drones into its platform. Kela competes on a relatively open, modular approach and aggressive pricing to win initial projects, and it intends to expand its operations and customer base, including plans to enter the U.S. market.

Participated · Series E · Apr 2026

Chapter offers an AI-native platform that powers licensed advisors to deliver personalized, impartial Medicare plan recommendations and help seniors maximize benefits. The company reviews every Medicare plan nationwide and has deployed products such as the most accurate provider directory and a prescription cost calculator for Medicare. Chapter reported rapid commercial traction in 2025, growing revenue threefold and surpassing $100 million in annual recurring revenue while maintaining flat corporate headcount. It is expanding its product set to launch additional financial products and to help members save across more of their spending. The business positions itself as the leading Medicare navigation option nationwide and partners with organizations to assist seniors with retirement healthcare decisions.

Led · Series C · Jan 2026

Founded in 2021, Pomelo Care delivers 24/7 virtual care to women and children via a multispecialty clinical team supported by an intelligent, data-driven platform that surfaces risk early and guides evidence-based interventions. The company partners with commercial and Medicaid health plans and employers, now covering more than 25 million lives and supporting nearly 7 % of all U.S. births. Outcomes published in peer-reviewed venues show a 37 % reduction in preterm births, a 46 % cut in emergency room visits, and a 6.8-day decrease in NICU length of stay, generating a 3-5× ROI for customers. Its technology embeds predictive analytics and clinical playbooks directly into clinician workflows while giving patients multimodal access to nurses, dietitians, therapists, doulas, and other providers. Beyond maternity, Pomelo has launched programs for pediatrics and midlife care; its perimenopause/menopause program has achieved an 88 % symptom reduction within 60 days and boosted patient-reported productivity by 73 %. With a proven model and national scale, the company aims to establish a new standard of longitudinal care for women and children while continuing rapid expansion with payers and employers.